CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 30,204 shares at an average $30.59 ($923,827)
- 4 Open-market sale 10% owner sold 4,796 shares at an average $30.03 ($144,024)
- 4 Open-market sale 10% owner sold 15,000 shares at an average $26.13 ($391,904)
- 4/A Open-market sale 10% owner sold 5,000 shares at $29.64 ($148,200)
- 4/A Open-market sale 10% owner sold 5,000 shares at $30.01 ($150,055)
- 4 Shares withheld for taxes Chief Financial Officer gave up 136,745 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President, ImprimisRx gave up 109,475 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 300,363 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 5,000 shares at $30.01 ($150,055)
- 4 Open-market sale 10% owner sold 5,000 shares at $29.64 ($148,200)
- 4 Open-market sale 10% owner sold 5,000 shares at $28.05 ($140,250)
- 4 Open-market sale 10% owner sold 20,000 shares at $35.59 ($711,814)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO of ImprimisRx gave up 45,140 shares (to pay taxes)
Page 2 of 15 · 296 filings